Related Experiment Video
Updated: Sep 18, 2025
Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform
Published on: November 30, 2016
Abnormal Homeostasis in the Redox State and Related Signaling Pathways, in Irritable Bowel Syndrome
A S Morales-Guzmán1,2, A Alarcón-Aguilar3, A Luna-López4
1Laboratory of Liver, Pancreas and Motility (HIPAM), Department of Experimental Medicine Dr. Ruy Pérez Tamayo, Faculty of Medicine, Universidad Nacional Autónoma de México (UNAM), Mexico City, Mexico.
Background:
IBS is multifactorial; however, elucidating its underlying mechanisms is crucial for advancing in its diagnosis and management.
Aims:
Evaluate molecular processes related to oxidative stress (OS) and inflammation in IBS and its subtypes.
Methods:
Thirty Rome III-IBS outpatients and 30 controls were studied for OS biomarkers, including malondialdehyde (MDA), protein carbonyls (PC), reduced glutathione (GSH), and oxidized glutathione (GSSG). Also, serum interleukins (IL-10, IL-4, TNF-α, IL-6), and the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB), nuclear factor erythroid 2-related factor 2 (Nrf2), and nicotinamide-adenine-dinucleotide phosphate (NADPH) catalytic subunit gp91phox.
Results:
In IBS vs. controls there were higher MDA: 4.44 ± 1.76 vs. 2.42 ± 0.5 nmol/mg/protein (p < 0.01); GSSG: 57.17 ± 17.49 vs. 42.73 ± 14.26 μM (p < 0.01); and lower GSH: 26.17 ± 12.36 vs. 38.47 ± 16.71 μM (p < 0.01). Also, an imbalance in pro- and anti-inflammatory interleukins (p < 0.01); and higher NF-κB: 5.33 ± 3.39 vs. 3.08 ± 1.19 (p = 0.01); gp91phox: 4.28 ± 1.81 vs. 3.29 ± 1.03 (p < 0.05); and lower Nrf2: 3.87 ± 2.9 vs. 7.56 ± 2.59 (p < 0.05). Additionally, there were no significant differences between the IBS subtypes, nor according to severity. Finally, in IBS-C, MDA correlated with IL-4, TNF-α with IL-10; and in IBS-D, GSH correlated with IL-4 and no differences in transcription factors.
Conclusions:
The data demonstrate an alteration in the homeostasis of the cellular redox state in IBS. Also, in IBS-D, the antioxidant effect counteracts the low-grade inflammation, whereas in IBS-C, it is mainly driven by interleukins.
Related Concept Videos
01:17Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
01:17Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:30Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
01:30Irritable Bowel Syndrome III: Medical and Nursing Management
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...